The Stem Cell Podcast

Ep. 80: “Gene Therapy in a Box” Featuring Dr. Jen Adair

Dec 6, 2016
Dr. Jen Adair, a translational gene therapy researcher at Fred Hutch and UW, works on retrovirus-based gene transfer and clinical-scale manufacturing of gene-modified blood stem cells. She describes automating and miniaturizing stem cell processing into a portable, bedside gene therapy lab. The conversation covers scaling for global access, safety improvements in lentiviral vectors, and adapting the platform for CAR‑T and other cell therapies.
Ask episode
AI Snips
Chapters
Transcript
Episode notes
INSIGHT

Translational Role In Gene Therapies

  • Adair positions her lab as the translational bridge: they scale molecular innovations into clinical-grade, manufacturable protocols.
  • She collaborates with groups that develop editing technologies and focuses on clinical-scale implementation.
INSIGHT

Portable Gene Therapy Lab

  • Jen Adair built a portable, modular gene-therapy manufacturing system to run clinical-grade HSC modification outside large GMP clean rooms.
  • The device automates selection, culture, and retroviral gene transfer to return a ready-to-infuse, gene-modified cell product to the clinic.
INSIGHT

Scale Requires Local Delivery Design

  • Scaling gene therapies globally requires thinking beyond efficacy to logistics, environment, and local clinical capacity.
  • Adair emphasizes building delivery methods that enable simultaneous evaluation across diverse populations.
Get the Snipd Podcast app to discover more snips from this episode
Get the app